Efficacy and safety of degludec versus glargine in type 2 diabetes
Pharmacy Today, American Pharmacists Association, pharmacist.com Researchers examined the cardiovascular safety of degludec, an ultralong-acting, once-daily basal insulin that is approved for use in adults, adolescents, and children with diabetes. They randomly assigned 7637 patients with type 2 diabetes to receive ... |
Social Plugin